Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
28%
OVERLAP
BY WEIGHT
20
# OF OVERLAPPING
HOLDINGS
BBP
57
HOLDINGS
33%
ALSO IN WDNA
WDNA
85
HOLDINGS
24%
ALSO IN BBP
SECTOR DRIFT (BBP minus WDNA)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BBP |
Weight in WDNA |
Overlap | |
|---|---|---|---|---|
 |
BRIDGEBIO PHARMA, INC. | 3.2% | 4.0% | 3.2% |
|
ALNYLAM PHARMACEUTICALS INC | 3.0% | 3.0% | 3.0% |
|
BLUEPRINT MEDICINES CORP. | 2.3% | 3.8% | 2.3% |
|
IONIS PHARMACEUTICALS, INC. | 2.7% | 2.1% | 2.1% |
|
GILEAD SCIENCES INC | 2.1% | 1.9% | 1.9% |
BBP Overweight Relative to WDNA
|
INSMED INC | 3.3% |
|
RHYTHM PHARMACEUTICALS, INC. | 3.0% |
|
MIRUM PHARMACEUTICALS, INC. | 3.0% |
|
BEIGENE LTD. SPONSORED ADR | 2.9% |
|
INTRA-CELLULAR THERAPIES INC | 2.6% |
|
ASCENDIS PHARMA A/S | 2.6% |
|
HALOZYME THERAPEUTICS INC | 2.6% |
|
PHATHOM PHARMACEUTICALS, INC. | 2.5% |
|
SAGE THERAPEUTICS INC | 2.5% |
|
LIGAND PHARMACEUTICALS-CL B | 2.4% |
BBP Underweight Relative to WDNA
|
NATERA INC | -4.4% |
 |
NOVOZYMES A/S-B SHARES | -3.2% |
|
STOKE THERAPEUTICS, INC. | -2.3% |
|
ELI LILLY & CO | -2.3% |
|
TWIST BIOSCIENCE CORP. | -2.2% |
|
VERACYTE INC | -2.1% |
 |
NOVARTIS AG | -1.9% |
|
VERICEL CORPORATION | -1.8% |
|
LABCORP HOLDINGS | -1.7% |
|
CORTEVA INC | -1.6% |